These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 1778874

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. In-vitro activity of imipenem combined with beta-lactam antibiotics for methicillin-resistant Staphylococcus aureus.
    Matsuda K, Asahi Y, Sanada M, Nakagawa S, Tanaka N, Inoue M.
    J Antimicrob Chemother; 1991 Jun; 27(6):809-15. PubMed ID: 1938687
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Synergistic enhancement of in vitro antimicrobial activity of imipenem and cefazolin, cephalothin, cefotiam, cefamandole or cefoperazone in combination against methicillin-sensitive and -resistant Staphylococcus aureus.
    Uete T, Matsuo K.
    Jpn J Antibiot; 1995 Mar; 48(3):402-8. PubMed ID: 7752453
    [Abstract] [Full Text] [Related]

  • 6. Synergic activity of imipenem/cilastatin combined with cefotiam against methicillin-resistant Staphylococcus aureus.
    Oka S, Goto M, Kaji Y, Kimura S, Matsuda K, Asahi Y, Sanada M, Nakagawa S, Inoue M, Shimada K.
    J Antimicrob Chemother; 1993 Apr; 31(4):533-41. PubMed ID: 8514648
    [Abstract] [Full Text] [Related]

  • 7. Synergistic enhancement of in vitro antimicrobial activity of cefmetazole and cefazolin, cefotiam, cefamandole or cefoperazone in combination against methicillin-sensitive and -resistant Staphylococcus aureus. I. Effect of NaCl.
    Uete T, Matsuo K.
    Jpn J Antibiot; 1995 Apr; 48(4):553-62. PubMed ID: 7783318
    [Abstract] [Full Text] [Related]

  • 8. In vitro activities of arbekacin, alone and in combination, against methicillin-resistant Staphylococcus aureus.
    Kono K, Takeda S, Tatara I, Arakawa K.
    Jpn J Antibiot; 1994 Jun; 47(6):710-9. PubMed ID: 8072179
    [Abstract] [Full Text] [Related]

  • 9. In vitro synergistic effects of double and triple combinations of beta-lactams, vancomycin, and netilmicin against methicillin-resistant Staphylococcus aureus strains.
    Rochon-Edouard S, Pestel-Caron M, Lemeland JF, Caron F.
    Antimicrob Agents Chemother; 2000 Nov; 44(11):3055-60. PubMed ID: 11036022
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Basic studies on combination effects of arbekacin and beta-lactam antibiotics on methicillin-resistant Staphylococcus aureus].
    Watanabe T, Sobu K, Takase Y, Kawabata T, Kanno M, Yoshida T.
    Jpn J Antibiot; 1994 Jun; 47(6):701-9. PubMed ID: 8072178
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. In vitro activity effects of combinations of cephalothin, dicloxacillin, imipenem, vancomycin and amikacin against methicillin-resistant Staphylococcus spp. strains.
    Miranda-Novales G, Leaños-Miranda BE, Vilchis-Pérez M, Solórzano-Santos F.
    Ann Clin Microbiol Antimicrob; 2006 Oct 12; 5():25. PubMed ID: 17034644
    [Abstract] [Full Text] [Related]

  • 14. Autolysis of methicillin-resistant Staphylococcus aureus is involved in synergism between imipenem and cefotiam.
    Matsuda K, Nakamura K, Adachi Y, Inoue M, Kawakami M.
    Antimicrob Agents Chemother; 1995 Dec 12; 39(12):2631-4. PubMed ID: 8592992
    [Abstract] [Full Text] [Related]

  • 15. [Clinical effect of the combined therapy of arbekacin and imipenem/cilastatin against methicillin-resistant Staphylococcus aureus].
    Hashimoto A, Ohtsubo T, Tomono K, Kaku M, Koga H, Kohno S, Hara K, Sugiyama H, Taira K, Inoue Y.
    Jpn J Antibiot; 1994 Jun 12; 47(6):804-12. PubMed ID: 8072190
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Bacteriological evaluations of combination effects with cefotiam and other antimicrobial agents against methicillin-resistant Staphylococcus aureus. II. Synergistic actions of cefotiam with arbekacin and minocycline].
    Deguchi K, Yokota N, Koguchi M, Suzuki Y, Suzuki K, Fukayama S, Ishihara R.
    Jpn J Antibiot; 1993 Feb 12; 46(2):123-9. PubMed ID: 8331772
    [Abstract] [Full Text] [Related]

  • 18. [Antibacterial activities of combination uses of isepamicin and beta-lactams in vitro against clinically isolated strains. Part 1. Activities against Staphylococcus aureus].
    Deguchi K, Koguchi M, Suzuki Y, Tanaka S, Fukayama S, Ishihara R, Oda S.
    Jpn J Antibiot; 1996 Feb 12; 49(2):194-202. PubMed ID: 8721079
    [Abstract] [Full Text] [Related]

  • 19. [Antibiotic efficacies of combined uses of arbekacin and various antibiotics against methicillin-resistant Staphylococcus aureus].
    Deguchi K, Yokota N, Koguchi M, Suzuki Y, Suzuki K, Fukayama S, Ishihara R, Oda S.
    Jpn J Antibiot; 1994 Jun 12; 47(6):693-700. PubMed ID: 8072177
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.